Metagenomi Quote - MGX

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

2.91

Bid

2.91

Offer

2.94

Volume

128,214

2.88 Day's Range 2.94

1.61 52 Week Range 12.74

Market Cap

108.904M

Previous Close

2.97

Open

2.94

Last Trade

2.918

Last Trade Time

01:43:34

Financial Volume

US$ 376,124

VWAP

2.9336

Average Volume (3m)

2,510,298

Shares Outstanding

37,423,917

Dividend Yield

PE Ratio

-1.63

Earnings Per Share (EPS)

-1.82

Revenue

44.76M

Net Profit

-68.26M

At Metageno-mi, we are cre-at-ing poten-tial-ly cura-tive ther-a-peu-tics using our metage--nomics-pow-ered genome edit-ing toolbox.We believe tools with capa-bil-i-ties that go beyond the cur-rent tech-nol-o-gy land-scape will be required in order to reach the full ther-a-peu-tic poten-tial of geno... At Metageno-mi, we are cre-at-ing poten-tial-ly cura-tive ther-a-peu-tics using our metage--nomics-pow-ered genome edit-ing toolbox.We believe tools with capa-bil-i-ties that go beyond the cur-rent tech-nol-o-gy land-scape will be required in order to reach the full ther-a-peu-tic poten-tial of genome edit-ing. By har-ness-ing the pow-er of metage-nomics, the study of genomes recov-ered from uncul-ti-vat-ed organ-isms in the nat-ur-al envi-ron-ment, we are dis-cov-er-ing and devel-op-ing a suite of nov-el genome edit-ing tools with the poten-tial to make any desired ther-a-peu-tic gene edit, any-where in the human genome. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.metagenomi.co

Headquarters

Wilmington, Delaware, USA

Founded

Metagenomi Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker MGX. The last closing price for Metagenomi was US$2.97. Over the last year, Metagenomi shares have traded in a share price range of US$ 1.61 to US$ 12.74.

Metagenomi currently has 37,423,917 shares in issue. The market capitalisation of Metagenomi is US$111.15 million. Metagenomi has a price to earnings ratio (PE ratio) of -1.63.

Form 8-K - Current report

Metagenomi Highlights Progress Across Therapeutic Portfolio and Outlines Anticipated Milestones

MGX-001 in Hemophilia A Advances Towards US and Ex-US Regulatory Interactions in 2025 NHP Proof-of-Concept Anticipated for Secreted Protein Deficiency Platform in 2025 Leveraging MGX-001 Editing...

Metagenomi Announces New Appointment to its Board of Directors

EMERYVILLE, Calif., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its...

Metagenomi to Present at the 43rd Annual J.P. Morgan Healthcare Conference

EMERYVILLE, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its...

Metagenomi Presents Highly Specific and Efficient Genome Editing Tools at Nature Conference “RNA at the Bench and Bedside IV”

MGX-001, utilizing a highly specific and efficient MG29-1 nuclease, exhibits no identifiable off-target editing MG29-1 nuclease targeting the albumin safe harbor locus showed no evidence of...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.262	9.89425981873	2.648	4	2.55	7309345	2.94851197	CS
4	-0.83	-22.192513369	3.74	4.055	2.55	1898677	3.04323005	CS
12	0.81	38.5714285714	2.1	4.92	1.61	2510298	3.64890691	CS
26	-1.51	-34.1628959276	4.42	4.92	1.61	1232260	3.52341558	CS
52	-7.34	-71.6097560976	10.25	12.74	1.61	704190	4.03002021	CS
156	-7.34	-71.6097560976	10.25	12.74	1.61	704190	4.03002021	CS
260	-7.34	-71.6097560976	10.25	12.74	1.61	704190	4.03002021	CS

MGX - Frequently Asked Questions (FAQ)

What is the current Metagenomi share price?

The current share price of Metagenomi is US$ 2.91

How many Metagenomi shares are in issue?

Metagenomi has 37,423,917 shares in issue

What is the market cap of Metagenomi?

The market capitalisation of Metagenomi is USD 111.15M

What is the 1 year trading range for Metagenomi share price?

Metagenomi has traded in the range of US$ 1.61 to US$ 12.74 during the past year

What is the PE ratio of Metagenomi?

The price to earnings ratio of Metagenomi is -1.63

What is the cash to sales ratio of Metagenomi?

The cash to sales ratio of Metagenomi is 2.48

What is the reporting currency for Metagenomi?

Metagenomi reports financial results in USD

What is the latest annual turnover for Metagenomi?

The latest annual turnover of Metagenomi is USD 44.76M

What is the latest annual profit for Metagenomi?

The latest annual profit of Metagenomi is USD -68.26M

What is the registered address of Metagenomi?

The registered address for Metagenomi is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

What is the Metagenomi website address?

The website address for Metagenomi is www.metagenomi.co

Which industry sector does Metagenomi operate in?

Metagenomi operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
GITSGlobal Interactive Technologies Inc	US$ 1.82 (1,770.50%)	5.78k
JGAurora Mobile Ltd	US$ 19.38 (222.35%)	13.75M
AKROAkero Therapeutics Inc	US$ 55.74 (112.91%)	4.56M
ETNB89bio Inc	US$ 11.215 (57.29%)	6.98M
HOLOMicroCloud Hologram Inc	US$ 2.3702 (52.92%)	88.88M
ALLKAllakos Inc	US$ 0.2925 (-75.83%)	11.2M
VERUVeru Inc	US$ 0.6999 (-42.16%)	13.28M
ELABPMGC Holdings Inc	US$ 1.8501 (-40.32%)	1.32M
NXUNXU Inc	US$ 0.40405 (-34.41%)	1.57M
ACONAclarion Inc	US$ 0.04 (-27.14%)	33.89M
NVDANVIDIA Corporation	US$ 127.65 (-10.50%)	100.11M
HOLOMicroCloud Hologram Inc	US$ 2.3702 (52.92%)	88.88M
ONCOOnconetix Inc	US$ 0.6653 (38.60%)	60.64M
MLGOMicroAlgo Inc	US$ 2.04 (34.21%)	42.07M
TVGNTevogen Bio Holdings Inc	US$ 1.6499 (22.21%)	34.09M